Christopher Plumpton

Title: Christopher Plumpton: Innovator in Neurological Treatments

Introduction

Christopher Plumpton is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of immunology, particularly in the treatment of neurological diseases. With a total of 2 patents, his work focuses on developing innovative therapeutic solutions.

Latest Patents

Plumpton's latest patents include "NOGO-a neutralising immunoglobulin for treatment of neurological diseases." This invention provides immunoglobulins, particularly antibodies that bind to NOGO and neutralize its activity. It also includes polynucleotides encoding such antibodies, pharmaceutical formulations containing these antibodies, and their use in treating and/or preventing neurological diseases. Another significant patent is related to immunoglobulins that specifically bind Oncostatin M (OSM), particularly human OSM (hOSM), and modulate the interaction between OSM and gp130. This invention also discusses antibodies that modulate the interaction between both Site II and Site III of OSM and their respective interacting partners, along with pharmaceutical compositions and medical treatment methods.

Career Highlights

Throughout his career, Christopher Plumpton has worked with prominent companies such as Glaxo Group Limited. His experience in these organizations has contributed to his expertise in developing innovative treatments.

Collaborations

Plumpton has collaborated with notable individuals in his field, including Jonathan Henry Ellis and Alexandre Eon-Duval. These collaborations have likely enhanced his research and development efforts.

Conclusion

Christopher Plumpton is a distinguished inventor whose work in immunology has the potential to significantly impact the treatment of neurological diseases. His innovative patents and collaborations reflect his commitment to advancing medical science.